CAR T cell therapy for pediatric brain cancer warrants further study
This study shows that this therapy can effectively get to the tumor, and the addition of C7R safely augments antitumor activity.
Read More
Baylor College of Medicine researchers set the foundation for novel rare disease treatment
The story behind the discovery that led to the novel treatment revealed that scientific breakthroughs can sometimes happen in unexpected ways.
Read More
CAR T cell therapy for T cell lymphoma shows promise in phase I trial
A first-in-human phase I clinical trial of patients with relapsed or refractory T cell lymphoma found early signals of anti-tumor efficacy and safety.
Read More
Rett patients receive a new gene therapy treatment at Texas Children’s Hospital and Baylor College of Medicine
Nearly 25 years after the discovery that mutations in MECP2 gene cause Rett syndrome, the first gene therapy trial for this difficult-to-treat condition is underway.
Read More
Can changing the gut microbiome alter the course of a disease?
A simple, safe dietary intervention has an effect on the gut microbiome and metabolites in these patients.
Read More
CAR NKT cells, a promising step forward in the treatment of solid tumors
An ongoing clinical trial shows that human CAR NKT cells are safe and, in 1 of 3 patients, induced regression of metastatic lesions.
Read More
ON A MATTER OF HEALTH: Clinical trial tests novel treatment strategy for ITP
The immune system is meant to protect the body from foreign invaders. A rare condition called immune thrombocytopenia (ITP) occurs when the body’s defense system
Read More
Orion shines a light in the dark for the blind
In a dark room inside Baylor College of Medicine, study participants are asked to look at a blacked out computer screen and point to a
Read More
From the labs to patent; osteoarthritis gene-therapy product is moving toward clinical trials
More than 30 million people in the United States alone are affected by osteoarthritis (OA), a degenerative joint disease, and that number is expected to
Read More
A new HER2 mutation leads to a clinical trial and to a promising diagnostic tool for metastatic breast cancer
There is a group of metastatic breast cancers that has the HER2 gene amplified – the cells have many copies of it – which leads
Read More